Toward an understanding of NSAID-related adverse events: The contribution of longitudinal data

Scandinavian Journal of Rheumatology, Supplement

Volumn 25, Issue 102, 1996, Pages 3-8

  Fries, J ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ARAMIS; DMARDs; Gastrointestinal toxicity; NSAIDs; Rheumatoid arthritis; Toxicity index

Indexed keywords

ACETYLSALICYLIC ACID; ANTIRHEUMATIC AGENT; IBUPROFEN; INDOMETACIN; MECLOFENAMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; SALSALATE;

AGE; CONFERENCE PAPER; DISABILITY; DISEASE COURSE; DISEASE SEVERITY; GASTROINTESTINAL TOXICITY; HOSPITALIZATION; HUMAN; MORTALITY; PREDICTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; FEMALE; GASTROINTESTINAL DISEASE; LONGITUDINAL STUDY; MALE; MIDDLE AGED; RHEUMATIC DISEASE; RISK FACTOR;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; FEMALE; GASTROINTESTINAL DISEASES; HOSPITALIZATION; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RHEUMATIC DISEASES; RISK FACTORS;

EID: 0029685134     PISSN: 03013847     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009749609097225     Document Type: Conference Paper

References (19)

1. Brooks PM. Side effects of non-steroidal anti-inflammatory drugs. Med J Aust 1988; 148:248-51.
2. Buchanan WW, Kean WF. Current non-steroidal anti-inflammatory drug therapy in rheumatoid arthritis, with emphasis on use in the elderly. In: Lewis AJ, Furst DE, Eds. Nonsteroidal Anti-inflammatory Compounds. Marcel Dekker, New York, 1987: 9-29.
3. Fries JF. The ARAMIS (American Rheumatism Association Medical Information System) Post-marketing Surveillance Program. Drug Info J 1985; 19:257-62.
4. Fries JF, McShane DJ. ARAMIS (American Rheumatism Association Medical Information System): A prototypical national chronic-disease data bank. West J Med 1986; 145:798-804.
5. Fries JF, Miller SR, Spitz PW, Williams CA, Hubert HB, Bloch DA. Toward an epidemiology of gastropathy associated with nonsteroidal anti-inflammatory drug use. Gastroenterol 1989; 96:647-55.
6. Fries JF, Williams CA, Bloch DA, Michel BA. Non-steroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models. Am J Med 1991; 91:213-22.
7. Mitchell DM, Spitz PW, Young DY, Bloch DA, McShane DJ, Fries J. Survival, prognosis and causes of death in rheumatoid arthritis. Arthritis Rheum 1986; 29:706-14.
8. Pincus T, Callahan LF. Taking mortality in rheumatoid arthritis seriously - predictive markers, socioeconomic status and co-morbidity. J Rheumatol 1986; 14:841-5.
9. Fries JF, Spitz PW, Williams CA, Bloch DA, Singh G, Hubert HB. A toxicity index for comparison of side effects among different drugs. Arthritis Rheum 1990; 33:121-30.
10. Fries JF, Williams CA, Bloch DA. The relative toxicity of non-steroidal anti-inflammatory drugs. Arthritis Rheum 1991; 34:1353-60.
11. Carson JL, Strom BL, Morse ML, West SL, Soper KA, Stolley PD, et al. The relative gastrointestinal toxicity of the non-steroidal anti-inflammatory drugs. Arch Intern Med 1987; 147:1054-9.
12. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Non-steroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991; 114:257-63.
13. Larkai EN, Smith JL, Lidsky MD. Gastroduodenal mucosa and dyspeptic symptoms in arthritis patients during chronic non-steroidal anti-inflammatory drug use. Am J Gastroenterol 1987; 82:1153-8.
14. Metropolitan Life Insurance Co. Anti-arthritis medication usage: United States 1991. Statistical Bulletin, July-September 1992.
15. Roth SJ, Bennet RE. Non-steroidal anti-inflammatory drag gastropathy: recognition and response. Arch Intern Med 1987; 147:2093-100.
16. Fries JF, Williams CA, Ramey DR, Bloch DA. The relative toxicity of disease modifying anti-rheumatic drugs (DMARDs). Arthritis Rheum 1993; 36:297-306.
17. Fries JF. Re-evaluating the therapeutic approach to rheumatoid arthritis: the "sawtooth" strategy. J Rheumatol 1990; 17 (Suppl 22):12-5.
18. Pincus T. The paradox of effective therapies but poor long-term outcomes in rheumatoid arthritis. Semin Arthritis Rheum 1992; 21 (Suppl 3):2-15.
19. Wilske KR, Healey LA. Remodelling the pyramid: a concept whose time has come. J Rheumatol 1989; 15:565-7.